000 01451 a2200409 4500
005 20250516140547.0
264 0 _c20130919
008 201309s 0 0 eng d
022 _a1532-9461
024 7 _a10.1016/j.semradonc.2012.11.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMouw, Kent W
245 0 0 _aClinical controversies: proton therapy for prostate cancer.
_h[electronic resource]
260 _bSeminars in radiation oncology
_cApr 2013
300 _a109-14 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDose-Response Relationship, Radiation
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasms
_xradiotherapy
650 0 4 _aOrgans at Risk
_xradiation effects
650 0 4 _aProstatic Neoplasms
_xradiotherapy
650 0 4 _aProton Therapy
_xadverse effects
650 0 4 _aQuality of Life
650 0 4 _aRadiation Oncology
_xmethods
650 0 4 _aRadiometry
_xmethods
650 0 4 _aRadiotherapy Dosage
650 0 4 _aRadiotherapy, Conformal
650 0 4 _aRadiotherapy, Intensity-Modulated
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aTrofimov, Alexei
700 1 _aZietman, Anthony L
700 1 _aEfstathiou, Jason A
773 0 _tSeminars in radiation oncology
_gvol. 23
_gno. 2
_gp. 109-14
856 4 0 _uhttps://doi.org/10.1016/j.semradonc.2012.11.009
_zAvailable from publisher's website
999 _c22565706
_d22565706